Profile | GDS4284 / 218941_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 649.592 | 68 |
GSM687648 | Patient 402 control | 1010.96 | 74 |
GSM687653 | Patient 403 control | 745.061 | 70 |
GSM687658 | Patient 404 control | 599.741 | 67 |
GSM687663 | Patient 411 control | 542.916 | 64 |
GSM687668 | Patient 422 control | 629.151 | 67 |
GSM687673 | Patient 424 control | 647.406 | 67 |
GSM687678 | Patient 425 control | 857.12 | 71 |
GSM687683 | Patient 427 control | 909.771 | 72 |
GSM687688 | Patient 428 control | 683.221 | 68 |
GSM687695 | Patient 441 control | 1427.43 | 81 |
GSM687699 | Patient 443 control | 931.105 | 73 |
GSM687704 | Patient 444 control | 511.988 | 64 |
GSM687707 | Patient 448 control | 860.303 | 72 |
GSM687712 | Patient 449 control | 700.011 | 69 |
GSM687719 | Patient 450 control | 898.121 | 72 |
GSM687724 | Patient 451 control | 352.682 | 58 |
GSM687728 | Patient 452 control | 663.15 | 68 |
GSM687646 | Patient 401 treated 24h | 704.222 | 68 |
GSM687649 | Patient 402 treated 24h | 900.848 | 72 |
GSM687665 | Patient 411 treated 24h | 640.601 | 67 |
GSM687651 | Patient 402 treated 4 weeks | 809.456 | 70 |
GSM687667 | Patient 411 treated 4 weeks | 877.248 | 72 |
GSM687670 | Patient 422 treated 24h | 783.553 | 70 |
GSM687671 | Patient 422 treated 4 weeks | 555.22 | 65 |
GSM687654 | Patient 403 treated 24h | 715.127 | 69 |
GSM687675 | Patient 424 treated 24h | 919.304 | 73 |
GSM687685 | Patient 427 treated 24h | 633.941 | 67 |
GSM687656 | Patient 403 treated 4 weeks | 839.804 | 71 |
GSM687677 | Patient 424 treated 4 weeks | 583.301 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 450.029 | 62 |
GSM687692 | Patient 428 treated 4h | 546.974 | 65 |
GSM687716 | Patient 449 treated 4h | 643.392 | 68 |
GSM687722 | Patient 450 treated 4h | 1019.21 | 74 |
GSM687680 | Patient 425 treated 24h | 749.905 | 69 |
GSM687690 | Patient 428 treated 24h | 595.795 | 67 |
GSM687700 | Patient 443 treated 24h | 841.971 | 70 |
GSM687705 | Patient 444 treated 24h | 979.373 | 74 |
GSM687714 | Patient 449 treated 24h | 756.213 | 70 |
GSM687721 | Patient 450 treated 24h | 1023.07 | 74 |
GSM687682 | Patient 425 treated 4 weeks | 716.808 | 69 |
GSM687694 | Patient 428 treated 4 weeks | 656.758 | 67 |
GSM687702 | Patient 443 treated 4 weeks | 831.088 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 563.296 | 66 |
GSM687723 | Patient 450 treated 4 weeks | 870.219 | 72 |
GSM687661 | Patient 404 treated 4h | 749.149 | 70 |
GSM687710 | Patient 448 treated 4h | 880.439 | 73 |
GSM687726 | Patient 451 treated 4h | 768.216 | 70 |
GSM687730 | Patient 452 treated 4h | 1045.41 | 75 |
GSM687660 | Patient 404 treated 24h | 1125.69 | 78 |
GSM687697 | Patient 441 treated 24h | 976.444 | 74 |
GSM687709 | Patient 448 treated 24h | 676.351 | 68 |
GSM687725 | Patient 451 treated 24h | 712.852 | 69 |
GSM687729 | Patient 452 treated 24h | 1284.61 | 80 |
GSM687727 | Patient 451 treated 4 weeks | 425.568 | 60 |
GSM687731 | Patient 452 treated 4 weeks | 817.441 | 71 |